Concepedia
Statistics
Publications
38
Citations
2.9K
H-Index
24
Active since
1987
Affiliations
Pfizer (United States)(Current)
Bristol-Myers Squibb (United States)
Imperial College London
Bristol-Myers Squibb (Germany)
University of Arizona
Donald G. Robertson is an author at Pfizer (United States) specializing in metabolomics, pharmacy, and biochemistry.
Publications per year
1987–2017
Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project
Chris Taylor, Dawn Field, Susanna‐Assunta Sansone et al. · Nature Biotechnology · 2008 · 562 citations · Full text
Pharmacy, Biomedical Sciences, Clinical Research Regulation +8
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
John C. Lindon, Jeremy K. Nicholson, Elaine Holmes et al. · Toxicology and Applied Pharmacology · 2003 · 386 citations · Full text
Pharmacy, Toxicology, Biochemical Toxicology +13
Metabonomics: Evaluation of Nuclear Magnetic Resonance (NMR) and Pattern Recognition Technology for Rapid in Vivo Screening of Liver and Kidney Toxicants
Donald G. Robertson · Toxicological Sciences · 2000 · 255 citations · Full text
Pharmacy, Pharmacology, Toxicology +17
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease
April D. Lake, Petr Novák, Petia Shipkova et al. · Amino Acids · 2014 · 233 citations · Full text
Medicine, Biochemistry, Molecular Medicine +10
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
April D. Lake, Petr Novák, Petia Shipkova et al. · Toxicology and Applied Pharmacology · 2013 · 190 citations
Life Sciences, Biochemistry, Toxicology +14
1–5 of 38